PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+10.27%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$3.22B
AUM Growth
+$3.22B
(-9.3%)
Cap. Flow
-$300M
Cap. Flow
% of AUM
-9.3%
Top 10 Holdings %
Top 10 Hldgs %
41.38%
Holding
91
New
22
Increased
22
Reduced
19
Closed
23
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$107M |
| 2 |
Amazon
AMZN
|
$99.4M |
| 3 |
Charles Schwab
SCHW
|
$91.5M |
| 4 |
Alibaba
BABA
|
$85.5M |
| 5 |
Lam Research
LRCX
|
$63.9M |
Top Sells
| 1 |
Pfizer
PFE
|
$166M |
| 2 |
UnitedHealth
UNH
|
$152M |
| 3 |
HCA Healthcare
HCA
|
$133M |
| 4 |
Gilead Sciences
GILD
|
$107M |
| 5 |
Eli Lilly
LLY
|
$92.6M |
Sector Composition
| 1 | Healthcare | 49.09% |
| 2 | Technology | 9.49% |
| 3 | Industrials | 8.41% |
| 4 | Financials | 7.83% |
| 5 | Communication Services | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $196M | 5.97% | 2,853,840 +778,063 | +37% | +$53.5M |
|
|
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
| $193M | 5.87% | 2,267,196 +108,029 | +5% | +$9.2M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $154M | 4.68% | 492,459 -116,330 | -19% | -$36.4M |
|
4
Palo Alto Networks
PANW
$127B
| $144M | 4.38% | 818,852 +279,001 | +52% | +$49.1M |
|
5
AerCap
AER
$22B
| $126M | 3.83% | 2,922,514 +828,523 | +40% | +$35.8M |
|
6
Teva Pharmaceuticals
TEVA
$21.1B
| $122M | 3.71% | 1,860,952 +322,087 | +21% | +$21.1M |
|
|
7
Alphabet (Google) Class A
GOOGL
$2.57T
| $107M | 3.25% | +137,536 | New | +$107M |
|
|
8
Amazon
AMZN
$2.44T
| $99.4M | 3.02% | +147,060 | New | +$99.4M |
|
9
Vulcan Materials
VMC
$38.5B
| $97.2M | 2.95% | 1,023,285 +93,385 | +10% | +$8.87M |
|
10
Edwards Lifesciences
EW
$47.8B
| $92.7M | 2.82% | 1,174,098 +386,668 | +49% | +$30.5M |
|
|
11
Charles Schwab
SCHW
$174B
| $91.5M | 2.78% | +2,779,577 | New | +$91.5M |
|
|
12
Alibaba
BABA
$322B
| $85.5M | 2.6% | +1,051,826 | New | +$85.5M |
|
|
MDCO
13
DELISTED
Medicines Co
MDCO
| $77.2M | 2.34% | 2,066,547 +776,895 | +60% | +$29M |
|
14
Heron Therapeutics
HRTX
$207M
| $74.2M | 2.25% | 2,777,464 -185,192 | -6% | -$4.94M |
|
|
CLVS
15
DELISTED
Clovis Oncology, Inc.
CLVS
| $72.7M | 2.21% | 2,078,440 -474,447 | -19% | -$16.6M |
|
16
Jazz Pharmaceuticals
JAZZ
$7.75B
| $71.9M | 2.19% | 511,850 +185,848 | +57% | +$26.1M |
|
17
Universal Health Services
UHS
$11.6B
| $68.6M | 2.08% | 573,905 +56,662 | +11% | +$6.77M |
|
18
Textron
TXT
$14.3B
| $66.1M | 2.01% | 1,573,009 +1,215,621 | +340% | +$51.1M |
|
|
19
Lam Research
LRCX
$127B
| $63.9M | 1.94% | +804,833 | New | +$63.9M |
|
|
ALDR
20
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $62.4M | 1.9% | 1,890,030 +784,119 | +71% | +$25.9M |
|
21
Synchrony
SYF
$28.4B
| $59.9M | 1.82% | +1,969,737 | New | +$59.9M |
|
|
AERI
22
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $57.8M | 1.76% | 2,374,797 +156,599 | +7% | +$3.81M |
|
|
AET
23
DELISTED
Aetna Inc
AET
| $56.6M | 1.72% | 523,340 -119,575 | -19% | -$12.9M |
|
|
ACOR
24
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $55.1M | 1.67% | 1,287,443 +373,769 | +41% | +$16M |
|
25
Meta Platforms (Facebook)
META
$1.86T
| $54.9M | 1.67% | 524,747 -567,399 | -52% | -$59.4M |
|